bipolar-disorder
(3)
Amae Health
Amae Health is a Los Angeles-based, psychiatry-led healthcare company building in-person outpatient clinics for people living with severe mental illness such as schizophrenia, bipolar disorder and treatment-resistant depression. Founded in 2022 by Stas Sokolin and Sonia Garcia, it pairs a wraparound clinical team - psychiatrists, therapists, primary care providers, dietitians, health coaches, peer mentors and social workers - with a data platform built on Palantir Foundry. The company reports a 30-day hospital readmission rate under 4% versus a 23% national average, and raised a $25M Series B in November 2025, bringing total funding to more than $50M.
Blue Oak Pharmaceuticals
Blue Oak Pharmaceuticals is a Waltham, Massachusetts biotech founded in 2016 to discover the next generation of drugs for brain disorders. Led by neurobiologist and former Eli Lilly and Sunovion executive Tom Large, the company designs novel, CNS-focused 'privileged chemotypes' and pairs them with systems-neurobiology behavioral assays and AI to hunt first-in-class small molecules for schizophrenia, bipolar disorder and treatment-resistant depression. Its work runs through partnerships with phenotypic-screening firm PsychoGenics and AI drug-design company Exscientia.
Freddie deBoer
Freddie deBoer is an American author, cultural critic, and PhD-wielding contrarian who has spent 17 years making everyone on the internet uncomfortable - including people who agree with him. A self-described Marxist who despises most of the left, his Substack newsletter 'cool but rude' has over 67,000 subscribers hungry for unvarnished takes on education, identity politics, media dysfunction, and mental illness. Author of three books - The Cult of Smart (2020), How Elites Ate the Social Justice Movement (2023), and debut novel The Mind Reels (2025) - deBoer writes with the conviction of someone who has nothing left to prove and everything left to say.